Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?

Objective: This study aims to examine the efficacy and safety of the antitumor necrosis factor (TNF) drugs in ankylosing spondylitis (AS) patients with chronic kidney disease. Methods: In this study, 24 male patients with a glomerular filtration rate (GFR) of <60 mL min(−1) 1.73 m(−2) were includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Coşkun, Belkıs Nihan, Yağız, Burcu, Gündüz Çorabay, Seniha, Pehlivan, Yavuz, Dalkılıç, Ediz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176218/
https://www.ncbi.nlm.nih.gov/pubmed/35546331
http://dx.doi.org/10.5152/eurjrheum.2022.21099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176218/
https://www.ncbi.nlm.nih.gov/pubmed/35546331
http://dx.doi.org/10.5152/eurjrheum.2022.21099

Ejemplares similares